METASTATIC OCULAR MELANOMA

This adverse event was reported 25 times

METASTATIC OCULAR MELANOMA is most prevalent among patients taking these drugs:

# Drug Count Frequency
0 TEBENTAFUSP 2 0.0033
1 NIVOLUMAB AND RELATLIMAB-RMBW 1 0.0019
2 PROPARACAINE HYDROCHLORIDE 1 0.0019
3 PEGCETACOPLAN 1 0.0005
4 ATOVAQUONE 1 0.0001
5 QUININE 1 0.0001
6 TESTOSTERONE CYPIONATE 1 0.0001
7 INSTALAX POLYETHYLENE GLYCOL 3350 1 0.0001
8 POLYETHYLENE GLYCOL 400 1 0.0001
9 SENNOSIDES 2 0.0001
See all drugs enriched for association with METASTATIC OCULAR MELANOMA